Save your place

Sign in to WhoBought

Please try again later.

Ray Dalio's Regeneron Pharmaceuticals, Inc. (REGN) position

Yes: as of Q1 2026, Ray Dalio holds 23K shares of REGN worth $17M (0.1% of the disclosed portfolio). Last quarter the position was reduced by 68.8%. First disclosed Q2 2021.
View full portfolio →
Current value
$17M
Shares held
23K
% of portfolio
0.1%
Est. average buy price (i)
$574.32
Quarter-end price
$768.97

Estimated trade prices

Average price in quarters with purchases
$640.58
Average prices in quarters with sales
  • Q1 2026: $765.64 (50K shares sold)
  • Q4 2025: $679.43 (163K shares sold)
  • Q4 2024: $839.22 (268 shares sold)
  • Q3 2024: $1,112.86 (5K shares sold)
  • Q2 2024: $969.40 (56K shares sold)
  • Q1 2024: $950.88 (49K shares sold)
  • Q3 2023: $785.91 (40K shares sold)
  • Q4 2022: $737.86 (19K shares sold)
  • Q3 2022: $629.39 (16K shares sold)
  • Q1 2022: $632.65 (2K shares sold)
  • Q3 2021: $620.82 (5K shares sold)

REGN price vs Dalio's position

1Y 3Y 5Y MAX
Dates
$500$1,000$1,50020222023202420252026Sold 5K shares (41.5%) · Q3 2021. Average closing price $620.82 · Price range $574.03–$680.965KsharessoldAdded 113 shares (1.5%) · Q4 2021. Average closing price $614.83 · Price range $543.48–$670.97113sharespurchasedSold 2K shares (27.6%) · Q1 2022. Average closing price $632.65 · Price range $595.12–$698.432KsharessoldAdded 68K shares (over 1,000%) · Q2 2022. Average closing price $650.01 · Price range $548.35–$738.8468KsharespurchasedSold 16K shares (22.2%) · Q3 2022. Average closing price $629.39 · Price range $573.97–$724.3216KsharessoldSold 19K shares (32.4%) · Q4 2022. Average closing price $737.86 · Price range $705.89–$766.3919KsharessoldAdded 26K shares (66.9%) · Q1 2023. Average closing price $754.21 · Price range $680.49–$826.9726KsharespurchasedAdded 36K shares (55.5%) · Q2 2023. Average closing price $771.00 · Price range $700.03–$830.3536KsharespurchasedSold 40K shares (39.8%) · Q3 2023. Average closing price $785.91 · Price range $692.45–$844.3740KsharessoldAdded 49K shares (81.3%) · Q4 2023. Average closing price $823.50 · Price range $775.18–$881.7049KsharespurchasedSold 49K shares (44.5%) · Q1 2024. Average closing price $950.88 · Price range $902.69–$993.3549KsharessoldSold 56K shares (91.2%) · Q2 2024. Average closing price $969.40 · Price range $883.20–$1,071.1956KsharessoldSold 5K shares (89.6%) · Q3 2024. Average closing price $1,112.86 · Price range $1,024.09–$1,201.765KsharessoldSold 268 shares (48.1%) · Q4 2024. Average closing price $839.22 · Price range $701.85–$1,046.91268sharessoldAdded 21K shares (over 1,000%) · Q1 2025. Average closing price $687.82 · Price range $634.14–$744.8321KsharespurchasedAdded 68K shares (324.2%) · Q2 2025. Average closing price $558.13 · Price range $483.07–$625.6068KsharespurchasedAdded 146K shares (164.3%) · Q3 2025. Average closing price $565.41 · Price range $534.91–$598.71146KsharespurchasedSold 163K shares (69.1%) · Q4 2025. Average closing price $679.43 · Price range $557.73–$787.32163KsharessoldSold 50K shares (68.8%) · Q1 2026. Average closing price $765.64 · Price range $733.04–$812.2750Ksharessold← Earlier —1 purchase
Average closing price · filing quarter
$765.64
Price range · filing quarter
$733.04 – $812.27
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −50K −$38M −68.8% 23K May 15, 2026
Q4 2025 Reduced −163K −$111M −69.1% 73K Feb 13, 2026
Q3 2025 Added +146K +$83M +164.3% 235K Nov 13, 2025
Q2 2025 Added +68K +$38M +324.2% 89K Aug 13, 2025
Q1 2025 Added +21K +$14M +7,163.3% 21K May 14, 2025
Q4 2024 Reduced −268 −$225K −48.1% 289 Feb 13, 2025
Q3 2024 Reduced −5K −$5.3M −89.6% 557 Nov 13, 2024
Q2 2024 Reduced −56K −$54M −91.2% 5K Aug 14, 2024
Q1 2024 Reduced −49K −$47M −44.5% 61K May 14, 2024
Q4 2023 Added +49K +$41M +81.3% 110K Feb 14, 2024
Q3 2023 Reduced −40K −$32M −39.8% 61K Nov 13, 2023
Q2 2023 Added +36K +$28M +55.5% 101K Aug 11, 2023
Q1 2023 Added +26K +$20M +66.9% 65K May 12, 2023
Q4 2022 Reduced −19K −$14M −32.4% 39K Feb 13, 2023
Q3 2022 Reduced −16K −$10M −22.2% 57K Nov 10, 2022
Q2 2022 Added +68K +$44M +1,255.5% 74K Aug 11, 2022
Q1 2022 Reduced −2K −$1.3M −27.6% 5K May 13, 2022
Q4 2021 Added +113 +$69K +1.5% 8K Feb 14, 2022
Q3 2021 Reduced −5K −$3.3M −41.5% 7K Nov 12, 2021
Q2 2021 New +13K +$6.4M – 13K Aug 13, 2021
Data through Q1 2026 · filed May 15, 2026
20 grouped rows from 20 quarters

More Dalio positions

Amazon.com, Inc.(AMZN)
$905M
4.1% of portfolio

NVIDIA Corporation(NVDA)
$812M
3.7% of portfolio

Alphabet Inc.(GOOGL)
$562M
2.6% of portfolio

Broadcom Inc.(AVGO)
$568M
2.5% of portfolio

Micron Technology, Inc.(MU)
$499M
2.2% of portfolio

Microsoft Corporation(MSFT)
$402M
1.8% of portfolio

Common questions

Does Ray Dalio own REGN?

Yes. As of Q1 2026, Ray Dalio disclosed 23K shares of REGN, worth $17M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ray Dalio buy REGN?

Ray Dalio first disclosed a REGN position in Q2 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ray Dalio sell REGN?

The quarter-by-quarter table above shows each sale and reduction Ray Dalio disclosed in REGN. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of REGN does Ray Dalio own?

Ray Dalio disclosed 23K shares of REGN as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ray Dalio pay for REGN?

Ray Dalio's estimated average buy price for REGN is $574.32, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.